Recombinant Tissue Plasminogen Activator (rTPA). Also referred to as "clot
buster." Must be given within three (3) hours of the onset of symptoms.
Not all stroke patients will meet the required criteria to have the rTPA
given, but those who do studies show they have have minimal to no neurological
deficits at three months after having a stroke. Approximately 3-5% of stroke
patients will receive rTPA since most patients delay in seeking medical
care past the three hour time limit.
Exclusion criteria is symptoms longer than the three hour window; bleeding
in the brain; blood pressure is too high; recent surgery; previous stroke
within the past three months; seizure onset with the present stroke.
Other medications used to prevent recurrent strokes include agents such
as: Anti-platelet agents; aspirin, Aggrenox, Plavix, and Ticlid. The anti-coagulating
drug agents are Heparin, which is given in the hospital and Coumadin. Coumadin
is taken in a pill form and can be given to the patients when they are discharged
from the hospital.
Another type of treatment involves surgery. The major arteries in the neck
(Carotid Arteries) if blocked can cause a stroke. A surgical procedure known
as a Carotid Endarterectomy can be performed if there is symptomatic disease
and the artery is at least 70% blocked.